Affiliation:
1. Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria
Abstract
ABSTRACT
Lung infections with multiresistant pathogens are a major problem among patients suffering from cystic fibrosis (CF).
N
-Chlorotaurine (NCT), a microbicidal active chlorine compound with no development of resistance, is well tolerated upon inhalation. The aim of this study was to investigate the
in vitro
bactericidal and fungicidal activity of NCT in artificial sputum medium (ASM), which mimics the composition of CF mucus. The medium was inoculated with bacteria (
Staphylococcus aureus
, including some methicillin-resistant
S. aureus
[MRSA] strains,
Pseudomonas aeruginosa
, and
Escherichia coli
) or spores of fungi (
Aspergillus fumigatus
,
Aspergillus terreus
,
Candida albicans
,
Scedosporium apiospermum
,
Scedosporium boydii
,
Lomentospora prolificans
,
Scedosporium aurantiacum
,
Scedosporium minutisporum
,
Exophiala dermatitidis
, and
Geotrichum
sp.), to final concentrations of 10
7
to 10
8
CFU/ml. NCT was added at 37°C, and time-kill assays were performed. At a concentration of 1% (10 mg/ml, 55 mM) NCT, bacteria and spores were killed within 10 min and 15 min, respectively, to the detection limit of 10
2
CFU/ml (reduction of 5 to 6 log
10
units). Reductions of 2 log
10
units were still achieved with 0.1% (bacteria) and 0.3% (fungi) NCT, largely within 10 to 30 min. Measurements by means of iodometric titration showed oxidizing activity for 1, 30, 60, and >60 min at concentrations of 0.1%, 0.3%, 0.5%, and 1.0% NCT, respectively, which matches the killing test results. NCT demonstrated broad-spectrum microbicidal activity in the milieu of CF mucus at concentrations ideal for clinical use. The microbicidal activity of NCT in ASM was even stronger than that in buffer solution; this was particularly pronounced for fungi. This finding can be explained largely by the formation, through transhalogenation, of monochloramine, which rapidly penetrates pathogens.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference52 articles.
1. Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives;Schmidt BZ;Clin Pharmacol,2016
2. Impact of gene editing on the study of cystic fibrosis
3. Repairing the basic defect in cystic fibrosis - one approach is not enough
4. Cystic fibrosis
5. Marshall BC ElbertAPetrenKRizviSFinkAOstrengaJSewallA. 2015. Cystic Fibrosis Foundation patient registry: annual data report 2014. Cystic Fibrosis Foundation,Bethesda, MD.